Clinical Trial Update: Vatalanib and Everolimus in Treating Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial results for the combination of vatalanib and everolimus in adults with advanced solid tumors, including kidney cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• Afinitor (everolimus)
• Vatalanib (vatalanib)

Snippet

Sponsor: Daniel George, MD | Conditions: Kidney Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED